Who invested in Hangzhou DAC Biotech Co., Ltd?
Hangzhou DAC Biotech Co., Ltd's investors include Citibank and Addor Capital.
Who invested in Hangzhou DAC Biotech Co., Ltd
Funding summaryUpdated 26 Oct 2026
$155Mraised across 1 round since 2021, from 1 source
- Latest round
- Series C, $155MMay 2021
- Investors
- 2
The rounds
- May 2021
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Hangzhou DAC Biotech Co., Ltd
How much has Hangzhou DAC Biotech Co., Ltd raised?
Hangzhou DAC Biotech Co., Ltd has raised $155M across 1 round since 2021.
When did Hangzhou DAC Biotech Co., Ltd last raise?
Hangzhou DAC Biotech Co., Ltd's most recent round was a Series C of $155M in May 2021.
What was Hangzhou DAC Biotech Co., Ltd's biggest round?
Its most recent round, $155M in May 2021, is also its largest on record.
Who backed Hangzhou DAC Biotech Co., Ltd first?
Hangzhou DAC Biotech Co., Ltd's first round on record, in May 2021, was backed by Citibank and Addor Capital.
What stage is Hangzhou DAC Biotech Co., Ltd at?
Hangzhou DAC Biotech Co., Ltd's latest named round is a Series C, in May 2021.
Companies like Hangzhou DAC Biotech Co., Ltd
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.